To study the biochemical consequences of the ALS-associated SPTLC2 E260K variant on a cellular level, we used patient derived fibroblasts that reflect the disease-associated stoichiometry of mutant and wildtype SPTLC2 protein that is relevant in vivo. This evidence concerns the gene SPTLC2 and amyotrophic lateral sclerosis.